DBT Call for Proposals 2026: Up to ₹15 Crore Funding for T Cell-Based Vaccines and Biologics
The Department of Biotechnology (DBT) has invited research proposals focused on T cell-based vaccines, biologics and engineered cellular therapies for major health challenges, including infectious diseases, cancer and autoimmune disorders. The call aims to support research ranging from fundamental T-cell biology and technology development to preclinical validation and early clinical development. The programme particularly focuses … Read more